Development of a tool to assess outpatient opioid use
Official title: Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Funded at Mmj Labs, LLC · NIH-11240717 · Data updated 2026-11-12
This study is working on a new tool to help doctors better understand how much opioids patients are using, which will help improve pain management and support treatments for those struggling with opioid use.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mmj Labs, LLC NIH-funded |
| Lab location | 1 site (Atlanta, UNITED STATES) |
| Project start | September 1, 2023 |
| Project end | December 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $455,972 |
| NIH project number | 4R44DA058952-02 |
| Project ID | NIH-11240717 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients who are prescribed opioids for pain management and are willing to report their usage accurately.
✕Less likely to help
Patients who do not use opioids or are not involved in outpatient pain management may not benefit from this research.
What this research studies
This research aims to create a Clinical Outcome Assessment (COA) tool that accurately measures outpatient opioid use reported by patients. It will utilize a standardized metric, milligrams of morphine equivalents (MME), to evaluate opioid consumption through a robust survey module. The tool is designed to support clinical trials and regulatory approval processes for interventions aimed at reducing opioid use and addressing substance use disorders. By capturing comprehensive data on opioid use, the tool will enhance the understanding of pain management practices and improve patient care.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for monitoring and managing opioid use, ultimately enhancing patient safety and treatment outcomes.
How similar studies have gone: Previous research has shown success in developing similar assessment tools for opioid use, indicating a promising avenue for this approach.
Where this research is happening
-
Mmj Labs, LLC
Atlanta, United States Active
Researchers
- Principal investigator: Baxter, Amy Lynn — Mmj Labs, LLC
- Study coordinator: Baxter, Amy Lynn
Related research
Other NIH-funded projects on the same topics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
-
Increasing Capacity at a Native Community Clinic to Improve Opioid Care for urban AI/AN
This grant helps a Native American health clinic build its research capacity to better serve urban American Indian and Alaska Native people dealing with opioid use disorder and related health issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.